For the first years of Korea’s institutional-only PEF regime, supervision of general partners was largely a possibility rather than a practice. That has changed, visibly and on the public record.
The sequence of publicly announced steps is worth laying out. The 2021 FSCMA amendment that created the institutional-only PEF category also gave the Financial Supervisory Service express inspection authority over GPs. In March 2025, Korean media reported that the FSS had requested organizational and internal-control materials from the thirty largest GPs by assets. In May 2025, the FSS publicly announced it would expand GP inspections to at least five per year — disclosing, in the same breath, how few it had conducted since 2021. In December 2025, the Financial Services Commission announced a PEF reform package including GP deregistration for grave violations, eligibility requirements and mandatory compliance officers for large GPs. In March 2026, the FSS and the PEF industry association published standard internal-control guidelines for GPs, with the FSS stating it would inspect how they are operated. And in July 2026, the FSS’s sanctions committee resolved what has been widely reported as the first heavy sanction pursued against a domestic institutional-only PEF GP.
Why it matters
None of this is a crisis, and this post reports only what is on the public record. But the direction is unambiguous: a regime that operated for years with minimal GP-level examination now has an inspection program, an internal-control benchmark, a reform bill and a sanction precedent. For GPs, supervisory attention is no longer a tail risk. For LPs — including the foreign LPs whose capital sits in these funds — the regulatory posture of the GP has become a diligence item with actual consequences: sanctions against a GP land, economically and reputationally, on the funds it manages and the investors in them.
The question map
- For a foreign LP already invested: what does the inspection expansion mean for your GP specifically — and what should you be asking it about internal controls, and about its readiness for examination?
- For an LP in diligence: how does a GP’s supervisory posture get assessed from outside — and which of the new public benchmarks are worth reading against the GP’s actual practice?
- For a GP: what do the inspections focus on, how are they conducted, and what does preparation look like? Those questions have answers, but they draw on experience beyond the public record and are not blog material.
- For everyone: does the reform legislation change the calculus — and on what timeline?
Where the answer turns
What this supervisory shift means in any particular case turns on facts such as the GP’s size and structure, its internal-control build-out against the new guidelines, the fund’s investor base, and where in the fund’s life the question arises. The public record tells you the weather is changing; it does not tell you what it means for your position.
If you are an LP in — or diligencing — a Korean PEF and want to think through what the new supervisory environment means for your commitment, see the Korean funds practice overview or get in touch.